A Case Crossover Study of Intermittent Fasting in CLL/SLL

Clinical trial NCT05708326 · COMPLETED

Trial details

NCT number: NCT05708326
Sponsor: British Columbia Cancer Agency
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)

Start date: 2023-06-12
Primary completion: 2023-10-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.